跳至主要内容
临床试验/NCT03650023
NCT03650023已完成不适用

A Crossover Trial of Chitosan Oligosaccharide (GO2KA1) on Post Prandial Glucose Control in Subjects With Normal Blood Glucose, Impaired Fasting Glucose and Impaired Glucose Tolerance

Yonsei University2 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2018年5月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
37
试验地点
2
主要终点
Glucose levels

研究概览

简要总结

It is well known that Chitosan oligosaccharide is low molecular weight and water soluble and chitosan oligosaccharide has been shown to reduce blood cholesterol and blood pressure, increase immunity, and enhance antitumor properties. the effect of chitosan oligosaccharide (GO2KA1) supplementation on glucose control in subjects with normal blood glucose, impaired fasting glucose and impaired glucose tolerance.

详细描述

A randomized, double-blinded, controlled, cross-over trial was conducted to verify the effects of chitosan oligosaccharide (GO2KA1). forty healthy male and female subjects aged 20-75 years with normal blood glucose, impaired fasting glucose and impaired glucose tolerance were recruited. The subjects visited the research site twice over with a seven-day interval after an overnight fast at least 12 hr. On the screening visit, the participants were the 2-hr oral glucose tolerance test (OGTT) was conducted. And they were separated normal blood glucose, impaired fasting glucose and impaired glucose tolerance. On the first visit, the participants were randomly assigned to consume a test or placebo product [test product: chitosan oligosaccharide powder 500mg (GO2KA1); placebo product: white egg powder 500mg] and ingested the assigned product. On the second visit, the participants consumed the other product that they did not eat on the first visit. On both visit day, the 2-hr oral sucrose tolerance test (OSTT) was conducted and started at 8:00 in the morning; venous blood samples were collected before (0 hr) and after ingestion (0.5, 1 and 2 hr) of the products.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 74 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Normal Blood Glucose (fasting blood sugar below 100mg/dl, two hours after meals below 140mg/dl)
  • Impaired Fasting Glucose (fasting blood sugar 100-125mg/dl)
  • Impaired Glucose Tolerance (two hours after meals 140-199mg/dl)

排除标准

  • history/presence of diabetes mellitus (including oral hypoglycaemic agent and insulin)
  • history of serious hypoglycemia
  • history of serious cardiovascular, cerebrovascular disease, pulmonary, gastrointestinal, hepatic, renal and/or haematological disease
  • uncontrolled blood pressure (blood pressure level more than 140/90mmHg)
  • history/presence of alcoholism, drug addiction, etc.
  • taking a regulation of blood glucose medications within 1 month before study
  • participation other intervention studies within 1 months before study
  • history of diagnosed with cancer, cancer surgery and hospitalization
  • women who are pregnant or desire to become pregnant during the study period
  • having any other medical condition which, in the opinion of the investigator, could interfere with participation in the study

研究组 & 干预措施

Chitosan Oligosaccharide (GO2KA1)

Experimental

Chitosan Oligosaccharide (GO2KA1) capsule was provided to the study participants. The Chitosan Oligosaccharide (GO2KA1) capsule was consumed within 15 min, and then 2-h oral sucrose tolerance test was conducted. The Chitosan Oligosaccharide (GO2KA1) one capsule had Chitosan Oligosaccharide 250mg.

干预措施: Chitosan Oligosaccharide (GO2KA1) (Dietary Supplement)

White egg

Placebo Comparator

White egg capsule was provided to the study participants. The White egg capsule was consumed within 15 min, and then 2-h oral sucrose tolerance test was conducted. The Chitosan Oligosaccharide (GO2KA1) one capsule had White egg 250mg.

干预措施: White egg (Dietary Supplement)

结局指标

主要结局

Glucose levels

时间窗: 2 hours

Glucose level differences during the 2-hr oral sucrose tolerance test between White egg and chitosan oligosaccharide (GO2KA1) intak

次要结局

  • The areas under the curve (AUC) of glucose(1 day of second visit (after finishing cross-over trial))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jong Ho Lee

Professor, PI

Yonsei University

研究点 (2)

Loading locations...

相似试验